Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

On the Importance of Rural Health: Mistaking a Forest for a Few Trees.

Nicoli CD, Sprague BL, Anker CJ, Lester-Coll NH.

Am J Clin Oncol. 2019 Nov;42(11):885. doi: 10.1097/COC.0000000000000613. No abstract available.

PMID:
31644445
2.

Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.

Evans MF, Vacek PM, Sprague BL, Stein GS, Stein JL, Weaver DL.

J Cell Biochem. 2019 Oct 8. doi: 10.1002/jcb.29409. [Epub ahead of print]

PMID:
31595577
3.

Screening mammography outcomes: risk of breast cancer and mortality by comorbidity score and age.

Demb J, Abraham L, Miglioretti DL, Sprague BL, O'Meara ES, Advani S, Henderson LM, Onega T, Buist DSM, Schousboe JT, Walter LC, Kerlikowske K, Braithwaite D.

J Natl Cancer Inst. 2019 Sep 6. pii: djz172. doi: 10.1093/jnci/djz172. [Epub ahead of print]

PMID:
31593591
4.

Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States.

Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, Conant EF, Hampton JM, Huang H, Kerlikowske K, Lee SJ, Miglioretti DL, Sprague BL, Tosteson ANA, Yaffe M, Stout NK.

J Natl Cancer Inst. 2019 Sep 10. pii: djz184. doi: 10.1093/jnci/djz184. [Epub ahead of print]

PMID:
31503283
5.

Survey Results Regarding Uptake and Impact of Synthetic Digital Mammography With Tomosynthesis in the Screening Setting.

Zuckerman SP, Sprague BL, Weaver DL, Herschorn SD, Conant EF.

J Am Coll Radiol. 2019 Aug 12. pii: S1546-1440(19)30864-6. doi: 10.1016/j.jacr.2019.07.020. [Epub ahead of print]

PMID:
31415739
6.

Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer.

Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ.

J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.

PMID:
31410813
7.

Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.

Bonafede MM, Miller JD, Pohlman SK, Troeger KA, Sprague BL, Herschorn SD, Winer IH.

Am J Prev Med. 2019 Sep;57(3):394-402. doi: 10.1016/j.amepre.2019.04.010. Epub 2019 Aug 1.

8.

Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium.

Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, Onega T, Quinn VP, Schapira MM, Tosteson ANA, Corley DA, Skinner CS, Schnall MD, Armstrong K, Wheeler CM, Silverberg MJ, Balasubramanian BA, Doubeni CA, McLerran D, Tiro JA.

J Natl Cancer Inst. 2019 Jul 11. pii: djz137. doi: 10.1093/jnci/djz137. [Epub ahead of print]

PMID:
31292633
9.

Strategies to Identify Women at High Risk of Advanced Breast Cancer During Routine Screening for Discussion of Supplemental Imaging.

Kerlikowske K, Sprague BL, Tosteson ANA, Wernli KJ, Rauscher GH, Johnson D, Buist DSM, Onega T, Henderson LM, O'Meara ES, Miglioretti DL.

JAMA Intern Med. 2019 Jul 1. doi: 10.1001/jamainternmed.2019.1758. [Epub ahead of print]

PMID:
31260054
10.

Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.

Nicoli CD, Sprague BL, Anker CJ, Lester-Coll NH.

Am J Clin Oncol. 2019 Jul;42(7):607-614. doi: 10.1097/COC.0000000000000549.

PMID:
31232724
11.

Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer.

Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL.

Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.

12.

Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.

Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL.

JAMA Intern Med. 2019 May 1;179(5):658-667. doi: 10.1001/jamainternmed.2018.8372. Erratum in: JAMA Intern Med. 2019 Apr 29;:.

PMID:
30882843
13.

Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL; Population-based Research Optimizing Screening Through Personalized Regimen (PROSPR) Consortium.

JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078.

PMID:
30816931
14.

Digital Breast Tomosynthesis: Radiologist Learning Curve.

Miglioretti DL, Abraham L, Lee CI, Buist DSM, Herschorn SD, Sprague BL, Henderson LM, Tosteson ANA, Kerlikowske K; Breast Cancer Surveillance Consortium.

Radiology. 2019 Apr;291(1):34-42. doi: 10.1148/radiol.2019182305. Epub 2019 Feb 26.

PMID:
30806595
15.

Airborne metals and polycyclic aromatic hydrocarbons in relation to mammographic breast density.

White AJ, Weinberg CR, O'Meara ES, Sandler DP, Sprague BL.

Breast Cancer Res. 2019 Feb 13;21(1):24. doi: 10.1186/s13058-019-1110-7.

16.

Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.

Fujii MH, Herschorn SD, Sowden M, Hotaling EL, Vacek PM, Weaver DL, Sprague BL.

AJR Am J Roentgenol. 2019 Mar;212(3):706-711. doi: 10.2214/AJR.18.20255. Epub 2019 Jan 23.

PMID:
30673339
17.

Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Arasu VA, Miglioretti DL, Sprague BL, Alsheik NH, Buist DSM, Henderson LM, Herschorn SD, Lee JM, Onega T, Rauscher GH, Wernli KJ, Lehman CD, Kerlikowske K.

J Clin Oncol. 2019 Apr 20;37(12):954-963. doi: 10.1200/JCO.18.00378. Epub 2019 Jan 9.

PMID:
30625040
18.

Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium.

Sprague BL, Kerlikowske K, Bowles EJA, Rauscher GH, Lee CI, Tosteson ANA, Miglioretti DL.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy210. [Epub ahead of print]

PMID:
30624682
19.

A Linkage Between Thyroid and Breast Cancer: A Common Etiology?

Bolf EL, Sprague BL, Carr FE.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):643-649. doi: 10.1158/1055-9965.EPI-18-0877. Epub 2018 Dec 12. Review.

PMID:
30541751
20.

Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population.

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE.

J Womens Health (Larchmt). 2019 Aug;28(8):1051-1059. doi: 10.1089/jwh.2018.6997. Epub 2018 Nov 27.

PMID:
30481098
21.

Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.

Sprague BL, Vacek PM, Herschorn SD, James TA, Geller BM, Trentham-Dietz A, Stein JL, Weaver DL.

Breast Cancer Res Treat. 2019 Feb;174(1):227-235. doi: 10.1007/s10549-018-5048-8. Epub 2018 Nov 17.

PMID:
30448897
22.

The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume.

Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL.

AJR Am J Roentgenol. 2018 Nov;211(5):957-963. doi: 10.2214/AJR.17.19350. Epub 2018 Sep 20.

23.

Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative Results.

McCarthy AM, Barlow WE, Conant EF, Haas JS, Li CI, Sprague BL, Armstrong K; PROSPR Consortium.

JAMA Oncol. 2018 Jul 1;4(7):998-1001. doi: 10.1001/jamaoncol.2018.0352. No abstract available. Erratum in: JAMA Oncol. 2018 Jul 1;4(7):1018.

24.

The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.

Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A.

Med Decis Making. 2018 Apr;38(1_suppl):99S-111S. doi: 10.1177/0272989X17711927.

25.

Contribution of Breast Cancer to Overall Mortality for US Women.

Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A.

Med Decis Making. 2018 Apr;38(1_suppl):24S-31S. doi: 10.1177/0272989X17717981.

26.

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, Gangnon R, Kurian AW, Weedon-Fekjaer H, Cronin KA, Plevritis SK.

Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624.

27.

Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment.

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B.

Acad Radiol. 2018 Sep;25(9):1118-1127. doi: 10.1016/j.acra.2017.12.028. Epub 2018 Feb 9.

28.

The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study.

Hart V, Trentham-Dietz A, Berkman A, Fujii M, Veal C, Hampton J, Gangnon RE, Newcomb PA, Gilchrist SC, Sprague BL.

Qual Life Res. 2018 May;27(5):1237-1247. doi: 10.1007/s11136-018-1807-6. Epub 2018 Feb 7.

29.

Beyond BI-RADS Density: A Call for Quantification in the Breast Imaging Clinic.

Conant EF, Sprague BL, Kontos D.

Radiology. 2018 Feb;286(2):401-404. doi: 10.1148/radiol.2017170644. Review. No abstract available.

30.

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, Lee SJ, van den Broek JJ, Huang X, Schechter CB, Sprague BL, Song J, de Koning HJ, Trentham-Dietz A, van Ravesteyn NT, Gangnon R, Chandler Y, Li Y, Xu C, Ergun MA, Huang H, Berry DA, Mandelblatt JS.

JAMA. 2018 Jan 9;319(2):154-164. doi: 10.1001/jama.2017.19130. Erratum in: JAMA. 2018 Feb 20;319(7):724.

31.

Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.

Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL.

Breast Cancer Res Treat. 2018 Feb;168(1):229-239. doi: 10.1007/s10549-017-4582-0. Epub 2017 Nov 28.

32.

Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):158-164. doi: 10.1158/1055-9965.EPI-17-0378. Epub 2017 Nov 17.

33.

Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ.

Conklin MW, Gangnon RE, Sprague BL, Van Gemert L, Hampton JM, Eliceiri KW, Bredfeldt JS, Liu Y, Surachaicharn N, Newcomb PA, Friedl A, Keely PJ, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):138-145. doi: 10.1158/1055-9965.EPI-17-0720. Epub 2017 Nov 15.

34.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

35.

Combining quantitative and qualitative breast density measures to assess breast cancer risk.

Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings SR, Miglioretti DL, Vachon CM, Shepherd JA.

Breast Cancer Res. 2017 Aug 22;19(1):97. doi: 10.1186/s13058-017-0887-5.

36.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

37.

Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium.

Yaghjyan L, Arao R, Brokamp C, O'Meara ES, Sprague BL, Ghita G, Ryan P.

Breast Cancer Res. 2017 Apr 6;19(1):36. doi: 10.1186/s13058-017-0828-3.

38.

Breast cancer screening in patients with cancers other than breast.

Leopold RB, Thomas AW, Concannon KF, Correll AD, LaPenta CM, Maurer SM, Sprague BL, Herschorn SD, Verschraegen CF.

Breast Cancer Res Treat. 2017 Jun;163(2):343-348. doi: 10.1007/s10549-017-4179-7. Epub 2017 Mar 6.

39.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

40.

Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline.

Wernli KJ, Arao RF, Hubbard RA, Sprague BL, Alford-Teaster J, Haas JS, Henderson L, Hill D, Lee CI, Tosteson ANA, Onega T.

J Womens Health (Larchmt). 2017 Aug;26(8):820-827. doi: 10.1089/jwh.2016.6076. Epub 2017 Feb 8.

41.

Aspirin use is associated with lower mammographic density in a large screening cohort.

Wood ME, Sprague BL, Oustimov A, Synnstvedt MB, Cuke M, Conant EF, Kontos D.

Breast Cancer Res Treat. 2017 Apr;162(3):419-425. doi: 10.1007/s10549-017-4127-6. Epub 2017 Feb 4.

PMID:
28160159
42.

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Oncol. 2017 Sep 1;3(9):1228-1236. doi: 10.1001/jamaoncol.2016.6326. Erratum in: JAMA Oncol. 2019 Sep 26;:.

43.

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801. Epub 2017 Jan 17.

44.

Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients.

Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Gen Intern Med. 2017 Apr;32(4):449-457. doi: 10.1007/s11606-016-3973-y. Epub 2017 Jan 9.

45.

Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ.

Veal CT, Hart V, Lakoski SG, Hampton JM, Gangnon RE, Newcomb PA, Higgins ST, Trentham-Dietz A, Sprague BL.

J Cancer Surviv. 2017 Jun;11(3):320-328. doi: 10.1007/s11764-016-0590-z. Epub 2017 Jan 5.

46.

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

47.

Co-occurring risk factors for current cigarette smoking in a U.S. nationally representative sample.

Higgins ST, Kurti AN, Redner R, White TJ, Keith DR, Gaalema DE, Sprague BL, Stanton CA, Roberts ME, Doogan NJ, Priest JS.

Prev Med. 2016 Nov;92:110-117. doi: 10.1016/j.ypmed.2016.02.025. Epub 2016 Feb 21.

48.

Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium.

Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE.

Breast Cancer Res Treat. 2016 Nov;160(2):323-331. Epub 2016 Sep 24.

49.

Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer-A Retrospective Cohort Study.

Johnson A, Shulman L, Kachajian J, Sprague BL, Khan F, James T, Cranmer D, Young P, Heimann R.

J Oncol Pract. 2016 Sep;12(9):e848-57. doi: 10.1200/JOP.2016.013409. Epub 2016 Aug 30.

50.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.

Supplemental Content

Loading ...
Support Center